{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:15:32Z","timestamp":1793153732807,"version":"4.5.0"},"reference-count":99,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["accp1.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Depression is common in pregnant women. However, the rate of antidepressant treatment in pregnancy is significantly lower than in nonpregnant women. Although some antidepressants may cause potential risks to the fetus, not treating or withdrawing the treatment is associated with relapsing and adverse pregnancy outcomes such as preterm birth. Pregnancy\u2010associated physiologic changes can alter pharmacokinetics (PK) and may impact dosing requirements during pregnancy. However, pregnant women are largely excluded from PK studies. Dose extrapolation from the nonpregnant population could lead to ineffective doses or increased risk of adverse events. To better understand PK changes during pregnancy and guide dosing decisions, we conducted a literature review to catalog PK studies of antidepressants in pregnancy, with a focus on maternal PK differences from the nonpregnant population and fetal exposure. We identified 40 studies on 15 drugs, with most data from patients taking selective serotonin reuptake inhibitors and venlafaxine. Most of the studies have relatively poor quality, with small sample sizes, reporting concentrations at delivery only, a large amount of missing data, and not including times and adequate dose information. Only four studies collected multiple samples following a dose and reported PK parameters. In general, there are limited data available regarding PK of antidepressants in pregnancy and deficiencies in data reporting. Future studies should provide accurate information on drug dosing and timing of dose, PK sample collection, and individual\u2010level PK data.<\/jats:p>","DOI":"10.1002\/jcph.2282","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T05:01:21Z","timestamp":1686805281000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetics of Antidepressants in Pregnancy"],"prefix":"10.1002","volume":"63","author":[{"given":"Min","family":"Yue","sequence":"first","affiliation":[{"name":"Purdue University College of Pharmacy  Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Kus","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine  Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Katta","sequence":"additional","affiliation":[{"name":"School of Informatics and Computing Indiana University Purdue University Indianapolis  Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Su","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine  Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Li","sequence":"additional","affiliation":[{"name":"The Ohio State University College of Medicine  Columbus OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Haas","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine  Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6554-0695","authenticated-orcid":false,"given":"Sara K.","family":"Quinney","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine  Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7638596"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-010-0176-0"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06111893"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.07.007"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.07.004"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-015-0524-1"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002535"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7801465"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.7.805"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2011.3466"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdr2.1074"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2628"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002160"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318261c372"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12r07966"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12r07967"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0233-3"},{"issue":"3","key":"e_1_2_8_19_1","first-page":"629","article-title":"What are the risks associated with different Selective Serotonin Re\u2010uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence","volume":"29","author":"Womersley K","year":"2017","journal-title":"Psychiatr Danub"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2022.4268"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312828"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.5.499"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004538"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-022-01372-x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0338-3"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdr2.1079"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.10.1541"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199602000-00015"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00958-6"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.5.993"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.7.720"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145704004286"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.06.040"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.1.145"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31815a57d8"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0419"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1103296"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2009.12.034"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06461"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181082"},{"key":"e_1_2_8_41_1","article-title":"Correlation between pharmacokinetics and pharmacogenetics of selective serotonin reuptake inhibitors and selective serotonin and noradrenaline reuptake inhibitors and maternal and neonatal outcomes: results from a naturalistic study in patients with affective disorders","author":"Colombo A","year":"2020","journal-title":"Hum Psychopharmacol"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.680177"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15533"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.01.019"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31818d2048"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-021-03122-z"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2746"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(02)17634-X"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02538.x"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181e7be23"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1263"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0214"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.2165\/11318050-000000000-00000"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.126181"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.02.010"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12188"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-011-0215-5"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M317"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2021.0191"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563659109025744"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1944-6"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-014-0421-z"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.071530"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.05.016"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000885"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.06.030"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2012.05.004"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2784"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318167d05b"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.167"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.24875\/AIDSRev.19000122"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.02.019"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.V35N3p181"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/1556-4029.13947"},{"key":"e_1_2_8_75_1","unstructured":"Data and Specimen Hub (DASH). Eunice Kennedy Shriver National Institute of Child Health and Human Development.https:\/\/dash.nichd.nih.gov\/"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2765"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241150-00002"},{"key":"e_1_2_8_78_1","unstructured":"Zoloft (sertraline hydrochloired) [package insert].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/019839S74S86S87_20990S35S44S45lbl.pdf"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199426030-00004"},{"key":"e_1_2_8_80_1","unstructured":"Prozac (fluoxetine hydrochloride) [package insert].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/018936s111lbl.pdf"},{"key":"e_1_2_8_81_1","unstructured":"Paxil (paroxetine hydrochloride) [package insert].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/020031s012 020710s047lbl.pdf"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328346063f"},{"key":"e_1_2_8_83_1","unstructured":"Celexa\u00ae(citalopram hydrobromide) [package insert].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020822s042 021046s019lbl.pdf"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746040-00002"},{"key":"e_1_2_8_85_1","unstructured":"Lexapro\u00ae (escitalopram oxalate) [package insert].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/021323s047lbl.pdf"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199427030-00002"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1515\/dmdi-2013-0053"},{"key":"e_1_2_8_88_1","unstructured":"Effexor\u00ae (venlafaxine hydrochloride) [package insert].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/020151s051lbl.pdf"},{"key":"e_1_2_8_89_1","unstructured":"Cymbalta (duloxetine hydrochloride) [package insert].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/21427lbl.pdf"},{"key":"e_1_2_8_90_1","unstructured":"Trazodone medical review. Center for drug evaluation and research.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/022411s000MedR.pdf"},{"issue":"3","key":"e_1_2_8_91_1","first-page":"1659","article-title":"The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways","volume":"277","author":"Nielsen KK","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_92_1","unstructured":"Anafranil (clomipramine hydrochloride) [package insert].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/019906s043lbl.pdf"},{"key":"e_1_2_8_93_1","unstructured":"Amitriptyline [package insert].https:\/\/s3\u2010us\u2010west\u20102.amazonaws.com\/drugbank\/fda_labels\/DB00321.pdf?1519147983"},{"key":"e_1_2_8_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00562502"},{"key":"e_1_2_8_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04382.x"},{"key":"e_1_2_8_96_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199018050-00002"},{"key":"e_1_2_8_97_1","unstructured":"Remeron (mirtazapine) [package insert].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/020415s023s024.pdf"},{"key":"e_1_2_8_98_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199605050-00007"},{"key":"e_1_2_8_99_1","unstructured":"Wellbutrin(bupropion hydrochloride) [package insert].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/018644s054lbl.pdf"},{"key":"e_1_2_8_100_1","doi-asserted-by":"publisher","DOI":"10.1080\/03602532.2019.1620763"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.2282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T03:45:49Z","timestamp":1692503149000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/jcph.2282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":99,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1002\/jcph.2282"],"URL":"https:\/\/doi.org\/10.1002\/jcph.2282","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"2022-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}